Avi Eisenthal

1.0k total citations
53 papers, 846 citations indexed

About

Avi Eisenthal is a scholar working on Immunology, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Avi Eisenthal has authored 53 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Immunology, 22 papers in Molecular Biology and 13 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Avi Eisenthal's work include Immune Cell Function and Interaction (22 papers), Immunotherapy and Immune Responses (18 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). Avi Eisenthal is often cited by papers focused on Immune Cell Function and Interaction (22 papers), Immunotherapy and Immune Responses (18 papers) and Monoclonal and Polyclonal Antibodies Research (13 papers). Avi Eisenthal collaborates with scholars based in Israel, United States and Germany. Avi Eisenthal's co-authors include S A Rosenberg, David H. Sachs, Eitan Shiloni, Steven A. Rosenberg, Alan Kawarai Lefor, Beatriz Lifschitz‐Mercer, Megan Sykes, Yehuda Skornick, Avi Hassner and René Lafrenière and has published in prestigious journals such as The Journal of Immunology, Annals of the New York Academy of Sciences and European Journal of Cancer.

In The Last Decade

Avi Eisenthal

51 papers receiving 808 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Avi Eisenthal Israel 17 558 241 237 138 86 53 846
Heather Jackson Australia 20 864 1.5× 383 1.6× 423 1.8× 79 0.6× 85 1.0× 37 1.2k
Uri Nir Israel 10 404 0.7× 181 0.8× 358 1.5× 114 0.8× 65 0.8× 13 826
Paul Hobby United Kingdom 16 954 1.7× 344 1.4× 218 0.9× 168 1.2× 72 0.8× 24 1.3k
Gary A. Truitt United States 9 422 0.8× 416 1.7× 385 1.6× 69 0.5× 53 0.6× 15 961
E K Gao United States 11 868 1.6× 132 0.5× 205 0.9× 82 0.6× 130 1.5× 13 1.2k
Deric D. Schoof United States 17 618 1.1× 406 1.7× 221 0.9× 96 0.7× 39 0.5× 34 866
Martin H. Goldrosen United States 16 283 0.5× 272 1.1× 160 0.7× 99 0.7× 35 0.4× 53 626
Thomas M. Fasy United States 17 334 0.6× 93 0.4× 241 1.0× 190 1.4× 37 0.4× 33 781
Heinz‐Joachim Radzun Germany 15 289 0.5× 235 1.0× 488 2.1× 84 0.6× 49 0.6× 38 1.0k
S Ohzeki Japan 9 396 0.7× 167 0.7× 169 0.7× 58 0.4× 31 0.4× 9 633

Countries citing papers authored by Avi Eisenthal

Since Specialization
Citations

This map shows the geographic impact of Avi Eisenthal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Avi Eisenthal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Avi Eisenthal more than expected).

Fields of papers citing papers by Avi Eisenthal

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Avi Eisenthal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Avi Eisenthal. The network helps show where Avi Eisenthal may publish in the future.

Co-authorship network of co-authors of Avi Eisenthal

This figure shows the co-authorship network connecting the top 25 collaborators of Avi Eisenthal. A scholar is included among the top collaborators of Avi Eisenthal based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Avi Eisenthal. Avi Eisenthal is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Brazowski, Eli, et al.. (2010). FOXP3 Expression in Duodenal Mucosa in Pediatric Patients with Celiac Disease. Pathobiology. 77(6). 328–334. 16 indexed citations
2.
Brazowski, Eli, Iris Dotan, Hagit Tulchinsky, Irina Filip, & Avi Eisenthal. (2009). Galectin-3 expression in pouchitis in patients with ulcerative colitis who underwent ileal pouch-anal anastomosis (IPAA). Pathology - Research and Practice. 205(8). 551–558. 14 indexed citations
3.
Eisenthal, Avi, et al.. (2008). A novel assessment of the quality of immunohistostaining overcomes the limitations of current methods. Pathology - Research and Practice. 204(5). 323–328. 1 indexed citations
4.
5.
Eisenthal, Avi, et al.. (2001). Expression of dendritic cells in ovarian tumors correlates with clinical outcome in patients with ovarian cancer. Human Pathology. 32(8). 803–807. 55 indexed citations
6.
Lifschitz‐Mercer, Beatriz, David J. Elliott, Josephine Issakov, et al.. (2001). Localization of a specific germ cell marker, DAZL1, in testicular germ cell neoplasias. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 440(4). 387–391. 20 indexed citations
7.
8.
9.
Eisenthal, Avi, Yehuda Skornick, Diana Buyaner, et al.. (1998). Human tumor cells, modified by a novel pressure/crosslinking methodology, promote autologous lymphocyte proliferation and modulate cytokine secretion. Cancer Immunology Immunotherapy. 46(6). 304–310. 8 indexed citations
10.
11.
Fixler, Dror, et al.. (1997). Monitoring of effector and target cell stimulation during conjugation by fluorescence polarization. Biology of the Cell. 89(7). 443–452. 6 indexed citations
12.
13.
Gutman, Mordechai, Avi Eisenthal, Gideon Goldman, et al.. (1996). Increased microvascular permeability induced by prolonged interleukin-2 administration is attenuated by the oxygen-free-radical scavenger dimethylthiourea. Cancer Immunology Immunotherapy. 43(4). 240–244. 19 indexed citations
14.
Eisenthal, Avi, et al.. (1993). Antitumor effects of recombinant interleukin-6 expressed in eukaryotic cells. Cancer Immunology Immunotherapy. 36(2). 101–107. 11 indexed citations
15.
Eisenthal, Avi, et al.. (1993). Induction of cell-mediated immunity against B16-BL6 melanoma in mice vaccinated with cells modified by hydrostatic pressure and chemical crosslinking. Cancer Immunology Immunotherapy. 36(5). 300–306. 13 indexed citations
16.
Eisenthal, Avi, et al.. (1993). Effect of allogeneic tumor cells, interleukin-2 and interleukin-6, on the growth of subcutaneous syngeneic tumors. Cancer Immunology Immunotherapy. 37(4). 233–239. 1 indexed citations
17.
18.
19.
Lefor, Alan Kawarai, Avi Eisenthal, & S A Rosenberg. (1988). Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts, and modified syngeneic blasts.. The Journal of Immunology. 140(11). 4062–4069. 31 indexed citations
20.
Eisenthal, Avi & Steven A. Rosenberg. (1988). Cross linking of anti-B16 melanoma monoclonal antibodies to lymphokine activated killer (LAK) cells: possible role in the therapy of B16 melanoma. Clinical & Experimental Metastasis. 6(5). 387–400. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heather Jackson Breakdown of academic impact, for papers by Uri Nir Breakdown of academic impact, for papers by Paul Hobby Breakdown of academic impact, for papers by Gary A. Truitt Breakdown of academic impact, for papers by E K Gao Breakdown of academic impact, for papers by Deric D. Schoof Breakdown of academic impact, for papers by Martin H. Goldrosen Breakdown of academic impact, for papers by Thomas M. Fasy Breakdown of academic impact, for papers by Heinz‐Joachim Radzun Breakdown of academic impact, for papers by S Ohzeki
Rankless by CCL
2026